Vascular Graft Market Insights
The global vascular graft market is anticipated to grow at a lucrative CAGR over the forecast period. Increasing occurrence of diseases such as diabetes, high blood pressure, and high cholesterol are likely to contribute towards the overall market growth. Also, genetic disorders and excessive smoking habits are likely to leave an adverse effect on over all individual’s health.
Vascular graft is a surgical procedure used to redirect blood flow from one area to another through reconnecting blood vessels. Demographic factors such as age also play an important role towards the market growth over the forecast period. Increase in average life expectancy of people has led to a rise in the geriatric population across the world, thereby contributing towards the growth.
Vascular Graft Market: Product Insights
The global vascular graft market is divided into endovascular stent graft, bypass graft, peripheral vascular graft, and hemodialysis access graft among others.
Endovascular stent grafts segment held the largest market share in 2016. The segment growth is attributed to increasing occurrence of high blood sugar, hypertension, and other factors leading to blockage of arteries.
Vascular Graft Market: Source Insights
Based on source, the global vascular graft market is segmented into Synthetic, Biological, and, Biosynthetic.
Synthetic vascular grafts are further divided into polytetrafluethylene, polyurethane, dacron, and others. The segment is likely to grow at a healthy rate over the forecast period due to its low or no post operational effects.
Biological vascular grafts are segmented into bovine vein, saphenous vein and, others. Biological materials are projected to dominate the overall market over the forecast period. This growth is likely to be driven by growing consciousness about improved biocompatibility, patient acceptance, and use of advanced technology resulting in better healthcare outcomes.
Biosynthetic segment is segregated into Ovine Collagen with Polyester and others. Polyester based grafts also accounted for a significant market share in 2016 due to easy availability of raw material, high tensile strength and, durability of grafts.
Vascular Graft Market: Application/ End-Use Insights
The global vascular graft market is divided into coronary artery disease, renal failure, vascular occlusion, and aneurysm among others. Cardiovascular diseases segment held the dominant share in the global market attributing to increasing number of patients suffering from hypertension, high blood sugar and other diseases.
The global vascular graft market is segmented into hospitals, ambulatory surgical centers, and specialty clinics among others. The hospital end user segment is projected to grow at a lucrative CAGR over the coming years due to high adoption of latest technological source & design availability in hospitals.
Vascular Graft Market: Regional Insights
North American market is likely to witness a significant CAGR over the forecast period due to factors such as increasing occurrence of cardiovascular diseases coupled with improved healthcare initiative programs for diabetes.
Moreover, Asia Pacific is projected to grow exponentially over the projected period. Increase in public and private healthcare expenditure coupled with penetration of healthcare insurance across the region is likely to boost the overall market growth.
Vascular Graft Market: End-Use Landscape
The end-use landscape includes a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase products from the global vascular graft market. The major consumers of the product are Cleveland Clinic, Mayo Clinic, and Johns Hopkins Hospital.
Vascular Graft Market Share & Competitor Analysis
Some of the key players profiled in the global vascular graft market include Medtronic plc, LeMaitre Vascular, Inc., Vascular Grafts Solutions Ltd., Heart Medical Europe BV, C.R. Bard, Inc., MAQUET Holding B.V. & Co. KG, Cook Medical, Inc., B. Braun Melsungen AG, ARTEGRAFT, and Vascutek Ltd. among others.